Deaths from drug overdoses see largest increase in US history

By Genevieve Leigh
7 June 2017

Deaths from drug overdoses jumped by the largest margin ever recorded in US history in 2016, according to preliminary data compiled by the New York Times. While the precise number will not be available until December due to the months it takes to certify an overdose death, the Times estimates that in 2016 more than 59,000 people died from drug overdoses, a 19 percent increase from 2015.

The scope of this public health crisis is immense. Drug overdoses now far surpass both the annual death toll from HIV/AIDS at the peak of the US epidemic in the late ’80s and early ’90s and the number killed in the country’s peak year of gun violence, 1993. It is now the leading cause of death among Americans under the age of 50.

The primary drugs responsible for deaths in recent years, accounting for more than half, are opioids. More Americans have died from opiate overdoses in the last two years than in the entire Vietnam War. Opiates include illegal drugs like heroin and drugs that are often legally prescribed for pain, such as hydrocodone and oxycodone (known by the brand names Vicodin and OxyContin, respectively).

Fentanyl, a synthetic pain killer, is the deadliest opioid and the drug that many blame for the rising death toll. Since 2014, fentanyl and its cousin, carfentanil, have proliferated dramatically. These drugs are extremely lethal. Less than half a teaspoon of pure fentanyl is enough to kill 10 people. Carfentanil, which is used as an elephant tranquilizer, is 5,000 times stronger than heroin. For a human, an amount of carfentanil equal to a few grains of salt can be a lethal dose.

Opioids, like many other highly addictive drugs, often sweep through entire towns and regions. In Ohio, fatal overdoses more than quadrupled in the past decade, according to the data analyzed by the Times. In Dayton, Ohio the number of overdose deaths reported in the first 33 days of this year is already more than half the yearly totals for the past two years. The coroner’s office for the county, overwhelmed with corpses, was forced to use refrigerated trucks to store bodies for up to a week on three separate occasions.

Kenneth M. Betz, director of the coroner’s office in Montgomery county, Ohio, told the Times, “Our staff is, quite frankly, tired. The doctors are tired. The investigators are tired. We’ve never had volumes like this.” These workers, along with rehab clinicians, youth counselors and emergency room staff witness the horrors of the epidemic on a daily basis.

Emergency responders on the front lines often see scores of overdoses in a single day when a “bad batch” of one or another drug arrives in a town. Social service workers in places like West Virginia and Florida have been flooded with cases of children who need homes due to the circumstances of their parents’ addiction. The overall psychological toll of these experiences on workers is devastating.

Drug abuse is a problem confronting all types of people regardless of skin color, gender, nationality or even income. However, the most devastating consequences of addiction are felt by the working class and poor.

Economically depressed areas with high poverty and unemployment, including regions devastated by deindustrialization, have become breeding grounds for drug abuse. Workers who suffer from job injuries and other physical ailments that come with poor health insurance and bad living conditions often become addicted to prescription drugs first before turning to the less expensive street versions.

Those whose prescriptions no longer suffice, or who have been cut off from their health insurance, are forced to buy drugs on the streets in communities often wracked by crime and violence.

The class character of the drug epidemic is most evident in treatment options. Rehab clinics that accept state insurance are scarce, overcrowded and always have long wait lists. Many have “one strike” policies in which an addict may not return if he ir she does not complete the program, despite the fact that experts put the relapse rate for opioid users as high as 80 percent.

Efforts to combat the drug epidemic have largely been limited to impotent local- and state-level measures. Many states, including Maryland, Arizona and Florida, have declared states of emergency over the crisis.

Pharmaceutical companies have played a decisive role in fostering the opioid epidemic. Prescriptions for opioids such as Percocet, OxyContin and Vicodin have skyrocketed, from 76 million in 1991 to nearly 259 million in 2012. This is enough to supply each American adult with “a bottle of pills and then some,” as US Surgeon General Vivek Murthy put it last year. A report issued in 2013 found that hydrocodone, the generic version of Vicodin, had been prescribed to more Medicare patients than any other drug in existence.

Drug companies go to great lengths to incentivize doctors to prescribe dangerous addictive painkillers to patients. Companies like Purdue Pharma have gone as far as creating promotional videos for advertising their drugs in waiting rooms, and doctors are given incentives for reaching a certain number of prescriptions.

The state of Ohio filed a lawsuit last week accusing five drug companies of abetting the opioid epidemic. However, no major drug companies have faced any serious consequences for their actions.

The most significant attempt to prosecute a pharmaceutical company was against Purdue Pharma. In 2007, three of the company’s executives were charged with misbranding the drug OxyContin and massively downplaying the possibility of addiction. All three pleaded guilty due to the sheer amount of evidence against them. The company settled with the US government for $635 million, a mere fraction of what was made off the drug, which brought in over $30 billion in sales over the two decades it was on the market.

The prosecution did nothing to curb the profit-hungry pharmaceutical companies or help the millions of people whose lives were destroyed by the drugs. A former sales representative for drug company Insys Therapeutics recently spoke out against almost identical practices. The whistleblower, Patty Nixon, said the company developed a scheme to get the highly addictive drug Subsys to patients who never should have had it. Subsys, which costs anywhere from $3,000 to $30,000 for a 30-day supply, contains fentanyl.

Nixon told NBC news that her job was to make sure Subsys got into the hands of “as many patients as possible.” The drug was designed to be used on cancer patients, but like many other opioids it has been widely pushed as a painkiller. One victim of the scheme, Sarah Fuller, was prescribed the drug for chronic neck and back pain from two car accidents. Sarah’s father told NBC News that when her doctor prescribed Subsys, an Insys sales rep was sitting in the room with them.

After Fuller’s prescription was tripled within the course of a month, she was found dead in her house. Prosecutors involved in Fuller’s case say the company paid hundreds of thousands of dollars to doctors in exchange for prescribing Subsys, a standard practice. Insys founder Dr. John Kapoor is a billionaire and among the wealthiest Americans.

The profiteering of giant drug companies mirrors that of every other corporate conglomerate, from the giant energy enterprises to agriculture and technology companies, all of which subordinate human need, and sometimes human life, to private profit.

Beyond the role of drug companies, the opioid epidemic is produced by a coalescence of the ills of capitalism. It is the expression of a profound social illness—the consequence of inequality, poverty, unemployment and a general feeling of hopelessness that afflicts broad sections of the population, combined with an economic and political system that leaves those most severely impacted by the social crisis to fend for themselves.